John E. Bailey, Jr

2020

In 2020, John E. Bailey, Jr earned a total compensation of $758.1K as Current Chief Executive Officer and President at G1 Therapeutics.

Compensation breakdown

Option Awards$542,109
Other$215,948
Total$758,057

Bailey received $542.1K in option awards, accounting for 72% of the total pay in 2020.

Bailey also received $215.9K in other compensation.

Rankings

In 2020, John E. Bailey, Jr's compensation ranked 9,698th out of 13,090 executives tracked by ExecPay. In other words, Bailey earned more than 25.9% of executives.

ClassificationRankingPercentile
All
9,698
out of 13,090
26th
Division
Manufacturing
4,176
out of 5,618
26th
Major group
Chemicals And Allied Products
1,712
out of 2,251
24th
Industry group
Drugs
1,501
out of 1,951
23rd
Industry
Pharmaceutical Preparations
1,106
out of 1,456
24th
Source: SEC filing on April 28, 2021.

Bailey's colleagues

We found five more compensation records of executives who worked with John E. Bailey, Jr at G1 Therapeutics in 2020.

2020

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2020

Soma Gupta

G1 Therapeutics

Chief Commercial Officer

2020

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

2020

Mark Avagliano

G1 Therapeutics

Chief Business Officer

2020

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

News

In-depth

You may also like